ClinicalTrials.Veeva

Menu

TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000

Topcon logo

Topcon

Status

Completed

Conditions

Healthy

Study type

Observational

Funder types

Industry

Identifiers

NCT02203981
TopQ_Maestro_OCT2000_001

Details and patient eligibility

About

To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • No known ocular pathologies

Exclusion criteria

  • Any known ocular pathologies

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems